Correlation Between Abcellera Biologics and Four Leaf

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Abcellera Biologics and Four Leaf at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcellera Biologics and Four Leaf into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abcellera Biologics and Four Leaf Acquisition, you can compare the effects of market volatilities on Abcellera Biologics and Four Leaf and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcellera Biologics with a short position of Four Leaf. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcellera Biologics and Four Leaf.

Diversification Opportunities for Abcellera Biologics and Four Leaf

0.59
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Abcellera and Four is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Abcellera Biologics and Four Leaf Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Four Leaf Acquisition and Abcellera Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcellera Biologics are associated (or correlated) with Four Leaf. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Four Leaf Acquisition has no effect on the direction of Abcellera Biologics i.e., Abcellera Biologics and Four Leaf go up and down completely randomly.

Pair Corralation between Abcellera Biologics and Four Leaf

Given the investment horizon of 90 days Abcellera Biologics is expected to generate 20.25 times more return on investment than Four Leaf. However, Abcellera Biologics is 20.25 times more volatile than Four Leaf Acquisition. It trades about 0.21 of its potential returns per unit of risk. Four Leaf Acquisition is currently generating about 0.17 per unit of risk. If you would invest  282.00  in Abcellera Biologics on October 30, 2024 and sell it today you would earn a total of  54.00  from holding Abcellera Biologics or generate 19.15% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Abcellera Biologics  vs.  Four Leaf Acquisition

 Performance 
       Timeline  
Abcellera Biologics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Abcellera Biologics disclosed solid returns over the last few months and may actually be approaching a breakup point.
Four Leaf Acquisition 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Four Leaf Acquisition are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Four Leaf is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Abcellera Biologics and Four Leaf Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Abcellera Biologics and Four Leaf

The main advantage of trading using opposite Abcellera Biologics and Four Leaf positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcellera Biologics position performs unexpectedly, Four Leaf can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Four Leaf will offset losses from the drop in Four Leaf's long position.
The idea behind Abcellera Biologics and Four Leaf Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk